[#item_full_content] Trulieve Cannabis is back in focus after an updated fair value estimate edges from CA$19.53 to CA$20.36, a measured reset rather than a sweeping overhaul. That shift lines up with broader Street research, where analysts are fine tuning price targets while keeping long term theses largely intact. As you read on, you will see how this revised target fits into the evolving analyst narrative and what it could mean for how you track Trulieve from here. Analyst Price Targets don’t always capture… Read More